Management of graft-versus-host disease

Vogeslang, 1988, Acute graft-versus-host disease: clinical characteristics in the cyclosporine era, Medicine, 67, 163, 10.1097/00005792-198805000-00003 Ferrara, 1991, Graft-versus-host disease, N Engl J Med, 324, 667, 10.1056/NEJM199103073241005 Lum, 1990, Immune recovery after bone marrow transplantation, Hematol Oncol Clin N Am, 4, 659, 10.1016/S0889-8588(18)30484-2 Bearman, 1988, regimen-related toxicity in patients undergoing bone marrow transplantation, Gastroenterology, 90, 460 Bearman, 1988, regimen-related toxicity in patients undergoing bone marrow transplantation, Gastroenterology, 90, 770 Weisdorf, 1990, Acute upper gastrointestinal graft versus host disease: Clinical significance and response to immunosuppressive therapy, Blood, 76, 624, 10.1182/blood.V76.3.624.624 Deeg, 1990, Management of acute graft-versus-host disease, Bone Marrow Transplantation, 6, 1 Nash, 1992, Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate, Blood, 80, 1838, 10.1182/blood.V80.7.1838.1838 Weisdorf, 1991, Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation, Transplantation, 51, 1197, 10.1097/00007890-199106000-00010 Beatty, 1985, Marrow transplantation from related donors other than HLA-identical siblings, N Engl J Med, 313, 765, 10.1056/NEJM198509263131301 Kerman, 1993, Retrospective analysis of 462 unrelated marrow transplants facilitated by the National Marrow Donor Program, N Engl J Med, 328, 593, 10.1056/NEJM199303043280901 McGlave, 1993, Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program, Blood, 81, 543, 10.1182/blood.V81.2.543.543 Storb, 1989, Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial, Blood, 73, 1729, 10.1182/blood.V73.6.1729.1729 Ramsay, 1982, A randomized study of the prevention of acute graft-versus-host disease, N Engl J Med, 306, 392, 10.1056/NEJM198202183060703 Chao, 1993, Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graftversus-host disease, N Engl J Med, 329, 1225, 10.1056/NEJM199310213291703 Poyton, 1988, T cell depletion in bone marrow transplantation, Bone marrow Transplantation, 3, 165 Young, 1992, T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission, Blood, 79, 3380, 10.1182/blood.V79.12.3380.3380 Champlin, 1990, Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation, Blood, 76, 418, 10.1182/blood.V76.2.418.418 Ash, 1990, Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors, N Engl J Med, 322, 485, 10.1056/NEJM199002223220801 Vallera, 1989, T cell depletion for graft-versus-host disease prophylaxis: a perspective on engraftment in mice and humans, Transplantation, 47, 751, 10.1097/00007890-198905000-00001 Weisdorf, 1990, Treatment of moderate/severe acute graft versus host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome, Blood, 75, 1024, 10.1182/blood.V75.4.1024.1024 Martin, 1990, A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment, Blood, 76, 1464, 10.1182/blood.V76.8.1464.1464 Martin, 1991, A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment, Blood, 77, 1821, 10.1182/blood.V77.8.1821.1821 Roy, 1992, Acute graft-versus-host disease following unrelated donor marrow transplantation: Failure of conventional therapy, Bone Marrow Transplantation, 10, 77 Hings, 1993, Prednisone therapy for acute graftversus-host disease: short- versus longterm treatment, Transplantation, 56, 577, 10.1097/00007890-199309000-00016 Enright, 1990, Avascular necrosis of bone: A common serious complication of allogeneic bone marrow transplantation, Am J Med, 89, 773, 10.1016/0002-9343(90)90214-X Juckett, 1991, Hemolytic uremic syndrome following bone marrow transplantation, Bone Marrow Transplantation, 7, 405 Deeg, 1990, Delayed complications and long-term effects after bone marrow transplantation, Hematol Oncol Clin North Am, 4, 641, 10.1016/S0889-8588(18)30483-0 Shapiro, 1988, Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation, Blood, 71, 1234, 10.1182/blood.V71.5.1234.1234 Byers, 1990, Use of an anti-pan T lymphocyte ricin A chain immunotoxin as targeted immunotherapy in steroid resistant acute graft vs. host disease, Blood, 75, 1426, 10.1182/blood.V75.7.1426.1426 Weisdorf, 1993, Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation, Bone Marrow Transplantation, 12, 531 Holler, 1990, Increased serum levels of tumour necrosis factor precede major complications of bone marrow transplantation, Blood, 75, 1011, 10.1182/blood.V75.4.1011.1011 Roy, 1993, Immunopathology of upper gastrointestinal acute graft-versus-host disease: Lymphoid cells and endothelial adhesion molecules, Transplantation, 55, 572, 10.1097/00007890-199303000-00022 McCarthy, 1991, Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-vs-host disease, Blood, 78, 1915, 10.1182/blood.V78.8.1915.1915 Bianco, 1991, Phase I–II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation, Blood, 78, 1205, 10.1182/blood.V78.5.1205.1205 Clift, 1993, A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation, Blood, 82, 2025, 10.1182/blood.V82.7.2025.2025 Flesch, 1992, Phase I–II trial of a monoclonal antitumour necrosis factor α antibody for the treatment of refractory severe acute graft-versus-host disease, Blood, 79, 3362, 10.1182/blood.V79.12.3362.bloodjournal79123362 Verfaillie, 1991, Candida infections in bone marrow transplant recipients, Bone Marrow Transplantation, 8, 177 Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 236, 845, 10.1056/NEJM199203263261301 Kahls, 1988, Functional asplenia after bone marrow transplantation: A late complication related to extensive chronic graft-versus-host disease, Ann Intern Med, 109, 461, 10.7326/0003-4819-109-6-461 Sullivan, 1990, Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation, N Engl J Med, 323, 705, 10.1056/NEJM199009133231103 Tuan, 1992, Pneumocystis carinii pneumonitis bone marrow transplantation, Bone Marrow Transplantation, 10, 267 Hertz, 1989, Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: A clinical approach and review of the literature, Medicine, 68, 269, 10.1097/00005792-198909000-00002 Wendt, 1992, Parainfluenza virus respiratory after bone marrow transplantation, N Engl J Med, 326, 921, 10.1056/NEJM199204023261404 Ely, 1991, Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease, Am J Med, 90, 707, 10.1016/S0002-9343(05)80059-2 Atkinson, 1990, Chronic graft-versus-host disease, Bone Marrow Transplantation, 5, 69 Loughran, 1990, Early detection and monitoring of chronic graft-versus-host disease, 631 Ochs, 1994, Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation, Bone Marrow Transplantation, 13, 455 Holland, 1988, Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG, Blood, 72, 621, 10.1182/blood.V72.2.621.621 Wingard, 1989, Predictors of death from chronic graft-versus-host disease after bone marrow transplantation, Blood, 74, 1428, 10.1182/blood.V74.4.1428.1428 Sullivan, 1988, Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease, Blood, 72, 555, 10.1182/blood.V72.2.555.555 Vogelsang, 1992, Thalidomide for the treatment oif chronic graft-versus-host disease, N Engl J Med, 326, 1055, 10.1056/NEJM199204163261604